Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Tofersen toont langdurig voordeel bij SOD1-ALS
mrt 2026 | Neuro-musculair